Evidence map›Paper›PMID 38525782›Full record

ArticleMethods and protocols2024

Effects on Quality of Life of a Telemonitoring Platform amongst Patients with Cancer (EQUALITE): A Randomized Trial Protocol.

Felipe Martínez, Carla Taramasco, Manuel Espinoza, Johanna Acevedo, Carolina Goic, Bruno Nervi

Open access · goldAbstract read
In one paragraph

Article in Methods and protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Felipe MartínezCentro para la Prevención y Control del Cáncer (CECAN), Santiago 8331150, Chile.
Carla TaramascoCentro para la Prevención y Control del Cáncer (CECAN), Santiago 8331150, Chile.ORCID 0000-0001-8318-4201
Manuel EspinozaCentro para la Prevención y Control del Cáncer (CECAN), Santiago 8331150, Chile.ORCID 0000-0001-9564-9512
Johanna AcevedoCentro para la Prevención y Control del Cáncer (CECAN), Santiago 8331150, Chile.
Carolina GoicCentro para la Prevención y Control del Cáncer (CECAN), Santiago 8331150, Chile.
Bruno NerviCentro para la Prevención y Control del Cáncer (CECAN), Santiago 8331150, Chile.ORCID 0000-0002-3016-7261
Pontificia Universidad Católica de Chile · CLUniversidad Andrés Bello · CLUniversidad del Desarrollo · CL

Funding

Agencia Nacional de Investigación y Desarrollo FONDAP ID 152220002
6 · The paper itself

Abstract

Cancer, a pervasive global health challenge, necessitates chemotherapy or radiotherapy treatments for many prevalent forms. However, traditional follow-up approaches encounter limitations, exacerbated by the recent COVID-19 pandemic. Consequently, telemonitoring has emerged as a promising solution, although its clinical implementation lacks comprehensive evidence. This report depicts the methodology of a randomized trial which aims to investigate whether leveraging a smartphone app called

Indexed as

adverse eventscancerinternetoncologypatient surveillancequality of lifesmartphonetelemonitoringtoxicity

Identifiers

PMID38525782
PMCPMC10961787
OpenAlexW4392864069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.